                </a></li></ul></div><p><strong>Figure 7.  <span>Histological pattern of cathepsin D expression in human cancers.</span></strong></p><a id="article1.body1.sec2.sec7.fig2.caption1.p1" name="article1.body1.sec2.sec7.fig2.caption1.p1"></a><p>Representative images of cathepsin D expression in human cancer samples.</p>
<a id="article1.body1.sec2.sec7.fig2.caption1.p2" name="article1.body1.sec2.sec7.fig2.caption1.p2"></a><p>(A) prostate (B) breast cancer showing cathepsin D expression (brown) by tumor and stromal cells; (C) large-cell lung carcinoma and (D) lung adenocarcinoma showing cathepsin D expression by tumor cells and to a lesser extent by stromal cells; (E, F), cathepsin D is almost exclusively expressed by stromal cells in small-cell lung carcinomas (E) and large-cell neuroendocrine carcinomas (F), whereas tumor cells are almost devoid of cathepin D expression.</p>
<a id="article1.body1.sec2.sec7.fig2.caption1.p3" name="article1.body1.sec2.sec7.fig2.caption1.p3"></a><p>Nuclei were counterstained with haematoxylin.</p>
<a id="article1.body1.sec2.sec7.fig2.caption1.p4" name="article1.body1.sec2.sec7.fig2.caption1.p4"></a><p>Magnification 200Ã—.</p>
<span>THISISTHEEND
